COVID-19
G2P Newsletter July 2021
Our G2P research team continues to be extraordinarily productive, publishing 21 scientific papers so far this year. This summer newsletter highlights a few of these papers, as well as G2P media features, blog posts, and policy recommendations.
Unlocking the human genetics of COVID
In an unprecedented international effort, researchers and clinicians tackle the genomics of COVID-19 risk. In this blog post, G2P Director Robert Green writes about what we’ve learned so far concerning genetics and COVID-19 and how the G2P research program has contributed to these growing studies.
Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection
The genetics of COVID vulnerability and the path to preventive genomics
In this talk for the National Hellenic Society, Dr. Robert Green, MD, MPH and Bethany Zettler, MS, CGC discuss the genetics of COVID vulnerability and how Genomes2People’s work has pivoted to support COVID-19 research during this pandemic.
Boston researchers using COVID-19 patients’ DNA to unlock secrets about impact of virus
Boston researchers using COVID-19 patients’ DNA to unlock secrets about impact of virus
Biobanks could identify medically actionable findings relevant for COVID-19 clinical care
Hospital records hold valuable Covid-19 data. Making it usable is time-consuming work
To help scientists around the globe study Covid-19, researchers in Boston have shared genetic and other clinical data from thousands of patients with an international consortium. That data includes information from dozens of people with Covid-19, who had donated blood samples and opened up their medical records before the pandemic.
Genetic counselors and the fight for medicare recognition
Elizabeth Fieg, MS, LCGC discusses the importance and implication of the H.R. 3235-The Access to Genetic Counselor Service Act that would authorize and recognize appropriately credentialed genetic counselors as reimbursable providers under Medicare.
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic
Coronavirus, the answer may be in your genes
What do your genetics have to do with your chances of dying from Coronavirus?
Our genes might make some of us more susceptible to COVID-19—but which genes? Geneticists are sharing their vast DNA databases to find out.
Heroes on the front line: Dr. Robert Green
“..There are researchers – every single scientist is thinking ‘how can I contribute?’”
Coronavirus: Genes may explain why some face greater danger than others
“While healthy young people as a group are less likely to have severe symptoms with COVID, they have to understand that some of them will become very ill and will even die from this infection,” Dr. Robert Green said. “No one should assume youth makes them invulnerable.”